AR049472A1 - DERIVATIVES OF 1,2,4 OXADIAZOL ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER. PHARMACEUTICAL COMPOSITIONS. - Google Patents

DERIVATIVES OF 1,2,4 OXADIAZOL ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER. PHARMACEUTICAL COMPOSITIONS.

Info

Publication number
AR049472A1
AR049472A1 ARP050100611A AR049472A1 AR 049472 A1 AR049472 A1 AR 049472A1 AR P050100611 A ARP050100611 A AR P050100611A AR 049472 A1 AR049472 A1 AR 049472A1
Authority
AR
Argentina
Prior art keywords
antagonists
pharmaceutical compositions
derivatives
oxadiazol
metabotropic glutamate
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Nps Pharma Inc
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Pharma Inc, Astrazeneca Ab filed Critical Nps Pharma Inc
Publication of AR049472A1 publication Critical patent/AR049472A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Los compuestos pertenecen a la categoría de derivados heterocíclicos de oxadiazoles utilizados como antagonistas del receptor mGluRS por su accion sobre el sistema nervioso. Composiciones farmacéuticas que los contienen. Reivindicacion 1:Un compuesto, o una de sus sales aceptables para uso farmacéutico, caracterizado porque se selecciona del grupo formado por los compuestos desde el 943 al 1006.The compounds belong to the category of heterocyclic derivatives of oxadiazoles used as antagonists of the mGluRS receptor by their action on the nervous system. Pharmaceutical compositions that contain them. Claim 1: A compound, or one of its salts acceptable for pharmaceutical use, characterized in that it is selected from the group consisting of the compounds from 943 to 1006.

ARP050100611 2004-02-18 2005-02-18 DERIVATIVES OF 1,2,4 OXADIAZOL ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER. PHARMACEUTICAL COMPOSITIONS. AR049472A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77986804A 2004-02-18 2004-02-18

Publications (1)

Publication Number Publication Date
AR049472A1 true AR049472A1 (en) 2006-08-09

Family

ID=36940522

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100611 AR049472A1 (en) 2004-02-18 2005-02-18 DERIVATIVES OF 1,2,4 OXADIAZOL ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER. PHARMACEUTICAL COMPOSITIONS.

Country Status (2)

Country Link
AR (1) AR049472A1 (en)
MY (1) MY148488A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9303024B2 (en) 2011-10-11 2016-04-05 Dana-Farber Cancer Institute, Inc. Pyrazol-3-ones that activate pro-apoptotic BAX
US9663529B2 (en) 2013-07-02 2017-05-30 Bristol-Myers Squibb Company Tricyclic pyrido-carboxamide derivatives as rock inhibitors
US9914740B2 (en) 2013-07-02 2018-03-13 Bristol-Myers Squibb Company Tricyclic pyrido-carboxamide derivatives as rock inhibitors
WO2023010192A1 (en) * 2021-08-02 2023-02-09 Eurofarma Laboratórios S.A. N-acylhydrazone compounds capable of inhibiting nav1.7 and/or nav1.8, processes for the preparation thereof, compositions, uses, methods for treatment using same, and kits

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9303024B2 (en) 2011-10-11 2016-04-05 Dana-Farber Cancer Institute, Inc. Pyrazol-3-ones that activate pro-apoptotic BAX
US10000478B2 (en) 2011-10-11 2018-06-19 Dana-Farber Cancer Institute, Inc. Pyrazol-3-ones that activate pro-apoptotic BAX
US10844053B2 (en) 2011-10-11 2020-11-24 Dana-Farber Cancer Institute, Inc. Pyrazol-3-ones that activate pro-apoptotic BAX
US9663529B2 (en) 2013-07-02 2017-05-30 Bristol-Myers Squibb Company Tricyclic pyrido-carboxamide derivatives as rock inhibitors
US9914740B2 (en) 2013-07-02 2018-03-13 Bristol-Myers Squibb Company Tricyclic pyrido-carboxamide derivatives as rock inhibitors
WO2023010192A1 (en) * 2021-08-02 2023-02-09 Eurofarma Laboratórios S.A. N-acylhydrazone compounds capable of inhibiting nav1.7 and/or nav1.8, processes for the preparation thereof, compositions, uses, methods for treatment using same, and kits

Also Published As

Publication number Publication date
MY148488A (en) 2013-04-30

Similar Documents

Publication Publication Date Title
UY31127A1 (en) METABOTROPIC RECEIVER OXYADAZOL LIGANDS FOR GLUTAMATE AND ITS USE AS POTENTIALS - 841
ECSP109856A (en) DERIVATIVES OF OXADIAZOL AND ITS USE AS POTENTIALS OF METABOTROPIC RECEIVERS OF GLUTAMATE - 842
DOP2010000375A (en) DERIVATIVES OF ISOXAZOL AND ITS USE AS POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS
CO6231028A2 (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF PROTEIN QUINASA
UY31940A (en) SUBSTITUTED DERIVATIVES OF 4,5- (SUBSTITUTED-PIRIDIN-3-IL) -1-METHYL-1H-INDOL, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, POLYMORPHOS, ROTÁMEROS, PRO-DRUGS, ANANTIOMERS, HYDRATES, SOLVATOS OF THE SAME AND COMPOSITIONS
UY28764A1 (en) POLYHETHEROCYCLIC COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER
UY29267A1 (en) PIPERIDINE DERIVATIVES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
UY28763A1 (en) TETRAZOL COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER
PE20181094A1 (en) CONDENSED HETEROCYCLIC DERIVATIVES REPLACED BY 2- (HET) ARILO AS PESTICIDES
UY29176A1 (en) SUBSTITUTED DERIVATIVES OF PURINA, PURINONA AND DEAZAPURINA, COMPOSITIONS THAT CONTAIN THEM, METHODS FOR THEIR PREPARATION AND ITS USES.
UY28775A1 (en) TETRAHYDROCHINOLINONES AND ITS USE AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS
UY29177A1 (en) SUBSTITUTED DERIVATIVES OF PURINA, PURINONA AND DEAZAPURINA, COMPOSITIONS THAT CONTAIN METHODS FOR THEIR PREPARATION AND ITS USES
UY28766A1 (en) ADDITIONAL HETEROPOLYCLIC COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER
AR063602A1 (en) DERIVATIVES OF SPIROINDOLINONE, PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM AND THEIR USE IN THE OBTAINING OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ONCOLOGICAL DISORDERS.
UY28765A1 (en) ACETILINIC PIPERAZINE COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEPTOR
GT200500175A (en) CETP INHIBITORS
CL2004000655A1 (en) COMPOUNDS DERIVED FROM PIPERIDIN-2-ONA 1,6-DISUSTITUTED, ITS SALTS, PHARMACEUTICAL COMPOSITION, AGONISTS OF THE EP4 RECEIVER; USE OF COMPOUNDS TO TREAT OCULAR HYPERTENSION, GLAUCOMA.
CR11518A (en) CARBAMOIL COMPOUNDS AS DGAT1 190 INHIBITORS
AR078278A1 (en) ANTAGONISTS OF TIAZOL AND OXAZOL HEPCIDINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME FOR THE TREATMENT OF ANEMIAS AND ILLNESSES ASSOCIATED WITH IRON DEFICIENCIES.
UY31863A (en) DRUG COMBINATIONS UNDERSTANDING A DGAT INHIBITOR AND A PPAR AGONIST
AR049276A1 (en) OPIOOD CARBOXAMID COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY29798A1 (en) CARBOXAMIDE DERIVATIVES AS ANTAGONISTS OF THE MUSCARINIC RECEIVER
DOP2010000226A (en) TRICICLIC COMPOUNDS THAT HAVE ANTAGONIST ACTIVITY OF CORTICOTROPINE RELEASE FACTOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
AR056860A1 (en) TRIAZOL DERIVATIVES INHIBITORS OF QUINASA TGF-BETA1 RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES FOR TUMOR TREATMENT
ECSP10010105A (en) CGRP ANTAGONISTS

Legal Events

Date Code Title Description
FB Suspension of granting procedure